Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NYSE:APR

Apria (APR) Stock Price, News & Analysis

Apria logo

About Apria Stock (NYSE:APR)

Key Stats

Today's Range
$37.50
$37.50
50-Day Range
$37.26
$37.50
52-Week Range
$22.36
$40.00
Volume
N/A
Average Volume
682,285 shs
Market Capitalization
$1.34 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Apria, Inc. provides integrated home healthcare equipment and related services in the United States. The company offers home respiratory therapies, including the supply of stationary and portable home oxygen equipment, and non-invasive ventilators; obstructive sleep apnea therapy devices comprising continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services; and negative pressure wound therapy products. It also provides a range of home medical equipment and other products, and services for patients with home care needs; and clinical and administrative support services, and related products and supplies to patients. Apria, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana. As of March 29, 2022, Apria, Inc. operates as a subsidiary of Byram Healthcare Centers, Inc.

Receive APR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apria and its competitors with MarketBeat's FREE daily newsletter.

APR Stock News Headlines

625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
Owens & Minor Announces New Partnership with Google Cloud
See More Headlines

APR Stock Analysis - Frequently Asked Questions

Apria, Inc. (NYSE:APR) released its quarterly earnings results on Thursday, November, 4th. The company reported $0.52 EPS for the quarter, topping analysts' consensus estimates of $0.48 by $0.04. The firm earned $287.20 million during the quarter, compared to analysts' expectations of $286 million. Apria had a net margin of 5.66% and a trailing twelve-month return on equity of 586.18%.

Apria (APR) raised $150 million in an initial public offering on Thursday, February 11th 2021. The company issued 7,500,000 shares at a price of $19.00-$21.00 per share. Citigroup and Goldman Sachs & Co. LLC BofA Securities J.P. Morgan UBS Investment Bank served as the underwriters for the IPO and Piper Sandler Citizens Capital Markets Fifth Third Securities TD Securities Academy Securities Blaylock Van, LLC Penserra Securities LLC Stern was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Apria investors own include Garmin (GRMN), WPP (WPP), Pan American Silver (PAAS), Argo Group International (ARGO), FirstCash (FCFS), Kinsale Capital Group (KNSL) and MSP Recovery (LIFW).

Company Calendar

Last Earnings
11/04/2021
Today
11/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Home Health Care Services
Sub-Industry
N/A
Fax
N/A
Employees
6,080
Year Founded
N/A

Profitability

Net Income
$64.88 million
Pretax Margin
7.84%

Debt

Sales & Book Value

Annual Sales
$1.15 billion
Cash Flow
$5.27 per share
Book Value
$1.12 per share

Miscellaneous

Free Float
N/A
Market Cap
$1.34 billion
Optionable
Not Optionable
Beta
N/A
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NYSE:APR) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners